Industry News & Alerts | Healthesystems

FDA Safety Alert - Zithromax (azithromycin): Risk of Cardiovascular Death

Fri, 18 May 2012 07:21:00 GMT

FDA is reviewing the results from a New England Journal of Medicine study reporting a small increase in cardiovascular deaths, in persons treated with a 5-day course of azithromycin

FDA News - Generic Versions of Plavix Approved

Fri, 18 May 2012 07:13:00 GMT

FDA approved generic versions of the blood thinning drug Plavix (clopidogrel bisulfate), which helps reduce the risk of heart attack and stroke

FDA Safety Alert - Tekturna

Mon, 23 Apr 2012 14:42:00 GMT

New Warning and Contraindication for blood pressure medicines containing aliskiren

FDA Safety Alert - Fentanyl Patches

Mon, 23 Apr 2012 12:45:00 GMT

FDA Reminds the Public about the Potential for Life-Threatening Harm from Accidental Exposure to Fentanyl Transdermal Systems (“Patches”)

FDA Safety Alert - Revised Recommendations for Celexa

Thu, 29 Mar 2012 09:47:00 GMT

related to a potential risk of abnormal heart rhythms with high doses

FDA Safety Alert - Label Changes to Cholesterol-lowering Statin Drugs

Tue, 28 Feb 2012 15:49:00 GMT

Changes were made to the labels to provide the public with more information for the safe and effective use of statins.

Voltaren gel 1% (Diclofenac Sodium Topical Gel) Shortage

Thu, 16 Feb 2012 15:45:00 GMT

This temporary shortage is not related to the efficacy or safety of Voltaren Gel.

FDA Safety Alert - Recall of Excedrin, NoDoz, Bufferin, Gas-X Prevention

Mon, 09 Jan 2012 14:59:00 GMT

Novartis Consumer Health Over-The-Counter Products: Recall - Potential Presence of Foreign Tablets or Chipped or Broken Tablets or Gelcaps

FDA Drug Safety Info - Certain Opiate Products Made for Endo Pharmaceuticals

Sun, 08 Jan 2012 15:48:00 GMT

FDA advises of potential safety risk associated with certain opiate products manufactured for Endo Pharmaceuticals by Novartis Consumer Health.

FDA Drug Info - FDA approves a class Risk Evaluation and Mitigation Strategy (REMS)

Tue, 03 Jan 2012 14:48:00 GMT

for transmucosal immediate-release fentanyl (TIRF) medicines

FDA Alert - Safety Announcement - Multaq

Tue, 20 Dec 2011 09:56:00 GMT

Review update of Multaq (dronedarone) and increased risk of death and serious cardiovascular adverse events

FDA News - FDA approves first generic version of Lipitor

Fri, 02 Dec 2011 08:12:00 GMT

(atorvastatin calcium tablets)

Watson Launches Generic Kadian

Tue, 22 Nov 2011 09:31:00 GMT

Watson Pharmaceuticals Inc. announced FDA approval for its Abbreviated New Drug Application for morphine sulfate ER capsules USP

FDA Alert - Review update of Trilipix & ACCORD Lipid trial

Fri, 11 Nov 2011 09:36:00 GMT

FDA warns that that the cholesterol-lowering medicine Trilipix (fenofibric acid) may not lower a patient's risk of having a heart attack or stroke.

NIH Study - Painkiller abuse treated by sustained buprenorphine/naloxone

Wed, 09 Nov 2011 09:45:00 GMT

NIH announces results from first large scale study on treatment of prescription opioid addiction

CDC Press Release - Prescription painkiller overdoses at epidemic levels

Tue, 01 Nov 2011 10:02:00 GMT

Kill more Americans than heroin and cocaine combined

FDA Warning Letter - Pfizer Webpage Complaint

Tue, 06 Sep 2011 10:42:00 GMT

Read the FDA Warning Letter and Notice of Violation Sent to Pfizer regarding Chantix^®, Caduet^® and Norvasc^®

FDA Drug Safety Info - Saphris (asenapine maleate)

Fri, 02 Sep 2011 10:54:00 GMT

Serious allergic reactions

FDA Drug Safety Info - Celexa (citalopram hydrobromide)

Thu, 01 Sep 2011 10:50:00 GMT

Abnormal Heart Rhythms Associated With High Doses

Drug Alert - Janssen Pharma Announces FDA Approval of NUCYNTA® ER

Mon, 29 Aug 2011 17:21:00 GMT

(tapentadol extended-release tablets) receives FDA approval for the management of moderate to severe chronic pain

FDA News - FDA approves Botox

Fri, 26 Aug 2011 10:59:00 GMT

To treat specific form of urinary incontinence

FDA Drug Safety Alert

Fri, 29 Jul 2011 10:01:00 GMT

Serious CNS reactions possible when linezolid (Zyvox®) is given to patients taking certain psychiatric medications

Drug Info - Tylenol® Products

Fri, 29 Jul 2011 09:20:00 GMT

Mcneil Consumer Healthcare Announces Plans For New Dosing Instructions For Tylenol® Products

FDA News - FDA approves Arcapta Neohaler

Thu, 28 Jul 2011 09:52:00 GMT

to treat chronic obstructive pulmonary disease

FDA News - FDA approves Potiga to treat seizures in adults

Thu, 28 Jul 2011 09:24:00 GMT

Potiga (ezogabine) tablets approved by FDA for use as add-on medication to treat seizures associated with epilepsy